High-risk surgical stage 1 endometrial cancer: Analysis of treatment outcome

Radiation Oncology

Volumn 1, Issue 1, 2005, Pages

  Viani, Gustavo A ^a   Patia, Barbara F ^a   Pellizzon, Antonio C ^a   De Melo, Marcel D ^a   Novaes, Paulo E ^a   Fogaroli, Ricardo C ^a   Conte, Maria A ^a   Salvajoli, Joao V ^a  

^a Department of Radiation Oncology Hospital do Cancer ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34248344977     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-1-24     Document Type: Article

References (21)

1. Aalders J Abeler V Kolstad P Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients Obstet Gynecol 1980 56 419-427 6999399
2. Meerwaldt JH Hoekstra CJ van Putten WL Endometrial adenocarcinoma, adjuvant radiotherapy tailored to prognostic factors Int J Radiat Oncol Biol Phys 1990 18 299-304 2303362
3. Grigsby PW Perez CA Kuten A Clinical stage I endometrial cancer: Prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system Int J Radiat Oncol Biol Phys 1992 22 905-911 1555983
4. Brady LW Perez CA Bedwinek JM Failure patterns in gynecologic cancer Int J Radiat Oncol Biol Phys 1986 12 549-557 3700163
5. Poulsen HK Jacobsen M Bertelsen K Adjuvant radiation therapy is not necessary in the management of endometrial carcinoma stage I, low-risk cases Int J Gynecol Cancer 1996 6 38-43 10.1046/ j.1525-1438.1996.06010038.x
6. Kucera H Vavra N Weghaupt K Benefit of external irradiation in pathologic stage I endometrial carcinoma: A prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors Gynecol Oncol 1990 38 99-104 10.1016/0090-8258(90)90018-G 2191908
7. Irwin C Levin W Fyles A The role of adjuvant radiotherapy in carcinoma of the endometrium: Results in 550 patients with pathologic stage I disease Gynecol Oncol 1998 70 247-254 10.1006/gyno.1998.5064 9740699
8. Greven KM Corn BW Endometrial cancer Curr Probl Cancer 1997 21 65-127 10.1016/S0147-0272(97)80002-5 9128804
9. Creasman WT Morrow CP Bundy BN Surgical pathologic spread patterns of endometrial cancer: A Gynecologic Oncology Group Study Cancer 1987 60 2035-2041 10.1002/1097-0142(19901015)60:8+<2035::AID- CNCR2820601515>3.0.CO;2-8 3652025
10. Creutzberg CL van Putten WL Koper PC Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomized trial - PORTEC Study Group, Post Operative Radiation Therapy in Endometrial Carcinoma Lancet 2000 355 1404-1411 10.1016/S0140-6736(00)02139-5 10791524
11. Roberts JA Brunetto VL Keys HM A phase III randomized study of surgery vs. surgery plus adjunctive radiation therapy in intermediate risk endometrial adenocarcinoma (GOG#99) Gynecol Oncol 1998 68 135 (abstr 250)
12. Straughn JM Jr Huh WK Orr JM Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy Gynecol Oncol 2003 89 295-300 10.1016/ S0090-8258(03)00087-8 12713994
13. Naumann RW Higgins RV Hall JB The use of adjuvant radiation therapy by members of the Society of Gynecologic Oncologists Gynecol Oncol 1999 75 4-9 10.1006/gyno.1999.5548 10502417
14. Koh WJ Tran AB Douglas JG Radiation therapy in endometrial cancer Best Pract Res Clin Obstet Gynaecol 2001 15 417-432 10.1053/beog.2001.0186 11476563
15. Greven KM Corn BW Case D Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation? Int J Radiat Oncol Biol Phys 1997 39 413-418 10.1016/ S0360-3016(97)00323-4 9308945
16. Jereczek-Fossa BA Postoperative irradiation in endometrial cancer: Still a matter of controversy Cancer Treat Rev 2001 27 19-33 10.1053/ ctrv.2000.0195 11237775
17. Inoue Y Obata K Abe K The prognostic significance of vascular invasion by endometrial carcinoma Cancer 1996 78 1447-1451 10.1002/ (SICI)1097-0142(19961001)78:7<1447::AID-CNCR11>3.0.CO;2-# 8839550
18. Cohn DE Horowitz NS Mutch DG Should the presence of lymphovascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol 2002 87 243-246 10.1006/gyno.2002.6825 12468320
19. Greven KM Randall M Fanning J Patterns of failure in patients with stage I, grade 3 carcinoma of the endometrium Int J Radiat Oncol Biol Phys 1990 19 529-534 2211200
20. Morrow CP Bundy BN Homesley HD Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: A Gynecologic Oncology Group Study Gynecol Oncol 1990 36 166-171 10.1016/0090-8258(90)90166-I 2298404
21. Randall ME Brunetto G Muss H Whole abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: A randomized phase III trial of the Gynecologic Oncology Group Proc Am Soc Clin Oncol 2003 22 2 (abstr 3)